We are live on ! Find out more
IART icon

Integra LifeSciences
IART

261 hedge funds and large institutions have $5.26B invested in Integra LifeSciences in 2021 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 101 increasing their positions, 75 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more repeat investments, than reductions

Existing positions increased: 101 | Existing positions reduced: 75

2.46% more ownership

Funds ownership: 88.46% → 90.91% (+2.5%)

3% more capital invested

Capital invested by funds: $5.09B → $5.26B (+$167M)

2% more call options, than puts

Call options by funds: $17.2M | Put options by funds: $16.8M

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 30

1% less funds holding

Funds holding: 264 → 261 (-3)

Holders
261
Holders Change
-3
Holders Change %
-1.14%
% of All Funds
4.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
30
Increased
101
Reduced
75
Closed
30
Calls
$17.2M
Puts
$16.8M
Net Calls
+$377K
Net Calls Change
-$1.33M

Top Buyers

1
AllianceBernstein
AllianceBernstein
Tennessee
+$140M
2
EVM
Eaton Vance Management
Massachusetts
+$75M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$25.7M
4
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
+$20.8M
5
Morgan Stanley
Morgan Stanley
New York
+$14.4M

Top Sellers

1
CIP
Champlain Investment Partners
Vermont
-$55.3M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$35.3M
3
CB
Cooke & Bieler
Pennsylvania
-$26.1M
4
Norges Bank
Norges Bank
Norway
-$17.2M
5
Jennison Associates
Jennison Associates
New York
-$12.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$658M +$25.7M +364,300 +4%
Capital Research Global Investors
2
Capital Research Global Investors
California
$565M -$140K -1,977 -0%
Vanguard Group
3
Vanguard Group
Pennsylvania
$457M +$1.48M +20,888 +0.3%
BlackRock
4
BlackRock
New York
$455M +$2.02M +28,549 +0.4%
CIP
5
Champlain Investment Partners
Vermont
$392M -$55.3M -782,793 -12%
Janus Henderson Group
6
Janus Henderson Group
United Kingdom
$284M -$35.3M -499,344 -11%
EVM
7
Eaton Vance Management
Massachusetts
$274M +$75M +1,061,750 +36%
ClearBridge Investments
8
ClearBridge Investments
New York
$175M -$374K -5,296 -0.2%
CB
9
Cooke & Bieler
Pennsylvania
$163M -$26.1M -368,755 -13%
AllianceBernstein
10
AllianceBernstein
Tennessee
$144M +$140M +1,986,060 +1,775%
State Street
11
State Street
Massachusetts
$132M +$1.69M +23,864 +1%
Macquarie Group
12
Macquarie Group
Australia
$96.4M +$380K +5,382 +0.4%
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$90.7M +$11M +155,011 +13%
Wells Fargo
14
Wells Fargo
California
$78M +$8.78M +124,291 +12%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$65M +$396K +5,609 +0.6%
ACM
16
Atlanta Capital Management
Georgia
$64.5M -$2.71M -38,423 -4%
Goldman Sachs
17
Goldman Sachs
New York
$58.4M -$1.95M -27,554 -3%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$51.4M +$6.03M +85,316 +13%
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$50.7M -$2.11M -29,873 -4%
Morgan Stanley
20
Morgan Stanley
New York
$50.3M +$14.4M +203,824 +38%
GKIM
21
GW&K Investment Management
Massachusetts
$49.5M -$274K -3,873 -0.5%
Northern Trust
22
Northern Trust
Illinois
$46.9M -$1.34M -19,023 -3%
ACH
23
ArrowMark Colorado Holdings
Colorado
$46.4M +$2.05M +28,961 +4%
Charles Schwab
24
Charles Schwab
California
$42.2M +$2.13M +30,154 +5%
Fisher Asset Management
25
Fisher Asset Management
Washington
$41.7M -$1.74M -24,638 -4%
1
2 3 4 5

IART Hedge Fund Activity: Q3 2021 in Review

261 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2021, worth a combined $5.26B — up 3.3% from $5.09B a quarter earlier.

Fund positioning in IART was balanced in Q3 2021: 30 funds opened new positions, 30 closed out, 101 added to existing stakes and 75 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $140M. The largest seller was Champlain Investment Partners, cutting an estimated $55.3M.

  • 261 institutional investors held Integra LifeSciences (IART) as of Q3 2021, down from 264 in Q2 2021.
  • Funds reported $5.26B of Integra LifeSciences stock for Q3 2021, up 3.3% quarter-over-quarter.
  • 30 funds opened new Integra LifeSciences positions in Q3 2021 and 30 closed out, a net change of 0 holders.
  • The largest Integra LifeSciences buyer in Q3 2021 was AllianceBernstein, an estimated $140M added.
  • The largest Integra LifeSciences seller in Q3 2021 was Champlain Investment Partners, an estimated $55.3M sold.

Based on aggregated 13F filings for Q3 2021.